Liver Cirrhoses: Clinical Trials

52 trials for Liver Cirrhoses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 17 unknown, 8 terminated, 7 recruiting. 22 Not applicable, 5 Phase 4, 4 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable22Unknown 12, Completed 6, Terminated 3, Recruiting 1
Phase 45Recruiting 2, Terminated 2, Completed 1
Phase 24Completed 2, Enrolling by invitation 1, Terminated 1
Phase 12Completed 1, Enrolling by invitation 1
Phase 31Completed 1

Follow Liver Cirrhoses: new trials by email Literature Review of Liver Cirrhoses trials Research Report on Liver Cirrhoses

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis
Liver Cirrhoses, Hepatocellular Carcinoma (HCC)
RecruitingMattias Ekstedt6002025-12-182025-12-19
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
Transjugular Intrahepatic Portosystemic Shunt (TIPS), Sleeve Gastrectomy, Anti-Obesity Pharmacotherapy (Class Effect) - Liver Cirrhoses, Portal Hypertension Related to Cirrhosis
Phase 4RecruitingThe Cleveland Clinic702025-12-172026-10-22
Evaluation of Chronic Liver Disease Condition and Transplant Prognosis Assisted by Eye Biological Parameters
Ophthalmic examination, General Condition Examination - Diagnostic Techniques, Ophthalmological, Liver Transplantation
RecruitingZhongshan Ophthalmic Center, Sun Yat-sen University5002022-03-012025-01-01
Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs
Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet, Sofosbuvir 400 MG + Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet - Hepatitis C, Liver Inflammation
Not applicableTerminatedKirby Institute212021-02-122026-05-26
Interventional Devascularization Plus HVPG-Guided Carvedilol Therapy vs TIPS
interventional devascularization, TIPS - Gastric Varices Bleeding, Liver Cirrhoses
Not applicableUnknownAir Force Military Medical University, China2122020-06-012020-02-05
HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients
Transjugular intrahepatic portosystemic shunt, Carvedilol, Endoscopic variceal ligation - Liver Cirrhoses, Variceal Hemorrhage
Not applicableUnknownAir Force Military Medical University, China2202020-06-012020-02-05
The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.
no intervention - Liver Cirrhoses
UnknownInstitute of Liver and Biliary Sciences, India10002020-04-102020-09-03
Assessing of Physicians' Knowledge About International Guidelines of Albumin Use in Patients With Liver Cirrhosis
Questionnaire about albumin use in liver cirrhosis - Liver Cirrhoses
Not applicableUnknownAbdelrahman Salah Eldin Abodief12020-04-012020-01-27
Liver Disease and Other Systemic Diseases
Liver Diseases, Humans
RecruitingTaipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation150002020-01-012025-09-19
Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCC
Diagnostic Sonazoid-CEUS and EOB-MRI - Hepatocellular Cancer, Liver Cirrhoses
Not applicableUnknownTianjin Third Central Hospital2002019-12-212022-12-13
Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit
Cycle ergometry - Liver Cirrhoses, Liver Failure
Not applicableTerminatedMedical College of Wisconsin972019-11-102024-03-20
Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis
Placebo oral tablet, Atorvastatin 10mg - Liver Cirrhoses
Phase 4TerminatedCopenhagen University Hospital, Hvidovre782019-11-082023-01-13
EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients.
Esophagogastroduodenoscopy, Endoscopic ultrasound - Liver Cirrhoses, Portal Hypertension
Not applicableUnknownInstituto Ecuatoriano de Enfermedades Digestivas352019-11-012019-12-09
Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC
Diagnostic CEUS and EOB-MRI - Hepatocellular Cancer, Liver Cirrhoses
Not applicableCompletedTianjin Third Central Hospital1152019-10-232022-03-07
Risk Factors of Liver Fibrosis Among First Degree Relatives of Patients With NASH Related Cirrhosis (NRC)
No intervention - Liver Cirrhoses
UnknownInstitute of Liver and Biliary Sciences, India6702019-09-182023-10-05
"To Study the Impact of Balloon-occluded Retrograde Transvenous Obliteration (BRTO)/Plug Assisted Retrograde Transvenous Obliteration (PARTO) Mediated Portal Flow Modulation in Reduction of Ammonia and Improvement in Organ Volume and Functionality in Patients of Cirrhosis With LR Shunt
Plug assisted retrograde transvenous obliteration/Balloon-occluded retrograde transvenous obliteration, Standard Medical Treatment - Liver Cirrhoses
Not applicableUnknownInstitute of Liver and Biliary Sciences, India502019-09-142019-11-13
Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites.
Transjugular Intrahepatic Portosystemic Shunt, Standard Medical Treatment - Liver Cirrhoses
Not applicableUnknownInstitute of Liver and Biliary Sciences, India802019-07-092019-08-28
Role of MRI in Detection of Minimal Hepatic Encephalopathy
Magnetic Resonance Imaging - Liver Cirrhoses, Hepatic Encephalopathy
UnknownUniversity Medical Centre Ljubljana402019-06-012019-10-18
Antibiotic-resistant Bacterial Infection of Hepatic Patients
microbiological culture and sensetivity - Antibiotic Resistant Infection, Liver Cirrhoses
UnknownAssiut University2002019-05-012019-02-27
Indirect Calorimeter Based Study in Patients With Liver Cirrhosis
Indirect calorimetry based nutritional intervention till patient in ICU(Intensive care unit), Standard and fixed nutritional intervention till patient in ICU - Liver Cirrhoses
Not applicableCompletedInstitute of Liver and Biliary Sciences, India832019-03-122022-10-24

Showing 20 of 52. Sign in to see all of them.

Narrower conditions

Hypertension, Portal (6)  ·  Liver Cirrhosis (6)  ·  Carcinoma, Hepatocellular (5)  ·  Esophageal and Gastric Varices (4)  ·  Fibrosis (4)  ·  Hepatitis C (4)  ·  Liver Diseases (4)  ·  Liver Neoplasms (3)  ·  Acute Kidney Injury (2)  ·  Hepatitis (2)  ·  Hepatitis B (2)  ·  Non-alcoholic Fatty Liver Disease (2)  ·  Sarcopenia (2)  ·  Ascites (1)  ·  Carcinogenesis (1)

Broader conditions

Digestive System Diseases (26)  ·  Liver Diseases (21)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Pathologic Processes (14)  ·  Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Carcinoma (6)  ·  Digestive System Neoplasms (6)  ·  Infections (6)  ·  Neoplasms by Histologic Type (6)  ·  Neoplasms, Glandular and Epithelial (6)  ·  Adenocarcinoma (5)  ·  Blood-Borne Infections (5)  ·  Communicable Diseases (5)  ·  Fibrosis (5)

Interventions

Portasystemic Shunt, Transjugular Intrahepatic (6)  ·  Propranolol (2)  ·  Acetylcysteine (1)  ·  Atorvastatin (1)  ·  Carvedilol (1)  ·  Diet Therapy (1)  ·  Endoscopy, Digestive System (1)  ·  Endosonography (1)  ·  Ertapenem (1)  ·  Glucagon-Like Peptide-1 Receptor Agonists (1)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  ICG 001 (1)  ·  Intensive Care Units (1)  ·  Magnetic Resonance Imaging (1)  ·  Nerve Conduction Studies (1)

Sponsors

Institute of Liver and Biliary Sciences, India (8)  ·  Air Force Military Medical University, China (3)  ·  Assiut University (2)  ·  Hvidovre University Hospital (2)  ·  Kirby Institute (2)  ·  Tianjin Third Central Hospital (2)  ·  University Hospital, Bonn (2)  ·  Abdelrahman Salah Eldin Abodief (1)  ·  Cedars-Sinai Medical Center (1)  ·  Centre Hospitalier Universitaire de NÄ«mes (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Copenhagen University Hospital, Hvidovre (1)  ·  Daegu Catholic University Medical Center (1)  ·  Dr.med. Monica Rusticeanu (1)  ·  Instituto Ecuatoriano de Enfermedades Digestivas (1)

Countries

India (8)  ·  United States (7)  ·  China (6)  ·  Germany (5)  ·  Denmark (3)  ·  France (3)  ·  Australia (2)  ·  Egypt (2)  ·  Switzerland (2)  ·  Taiwan (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Ecuador (1)  ·  Indonesia (1)  ·  Italy (1)

Top investigators

Jun Tie, M.D.,Ph.D. (2)  ·  Xiang Jing, MD (2)  ·  Aldo Torre, MD (1)  ·  Ali Aminian, MD (1)  ·  Andrea De Gottardi, MD (1)  ·  Borut Stabuc, M.D. (1)  ·  Ching-Sheng Hsu, Ph.D (1)  ·  Chyntia O Jasirwan, PhD (1)  ·  Claude B Sirlin, MD (1)  ·  Don Rockey, M.D (1)  ·  Dr Ankit Bhardwaj, Masters-CR (1)  ·  Dr Shiv Kumar Sarin, DM (1)  ·  Dusan Suput, M.D. (1)  ·  Flemming Bendtsen (1)

Results publications

PMID 11864921, PMID 17006913, PMID 29059466, PMID 31980514, PMID 32925554, PMID 33288401, PMID 33654016, PMID 35605429, PMID 35719155, PMID 35916685, PMID 36840793, PMID 37973887, PMID 38774417, PMID 39241828, PMID 39908052, PMID 40631454, PMID 40677691

NIH funding

2017 (1), R01CA218486 (1)